Trial Profile
Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse (Tenecteplase) in Korean Patients With Acute Myocardial Infarction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Tenecteplase (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions; Therapeutic Use
- Sponsors Boehringer Ingelheim
- 05 Aug 2014 New trial record